TransMedics Group, Inc.
NASDAQ: TMDX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Waleed H. Hassanein
- Employees
- 728
- Headquarters
- Andover, United States
- IPO year
- 2019
- Market cap
- $2.6B
- Website
- https://www.transmedics.com
Loading TMDX…
Loading profile data…Frequently asked questions about TMDX
What does TransMedics Group, Inc. (TMDX) do?
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, a...
Where does TMDX trade?
TransMedics Group, Inc. (TMDX) trades on the NASDAQ Global Market.
What sector is TMDX in?
TransMedics Group, Inc. (TMDX) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of TransMedics Group, Inc.?
Waleed H. Hassanein is the chief executive officer of TransMedics Group, Inc. (TMDX).
Where is TransMedics Group, Inc. headquartered?
TransMedics Group, Inc. is headquartered in United States.
Does TMDX pay a dividend?
TransMedics Group, Inc. (TMDX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TMDX go public?
TransMedics Group, Inc. (TMDX) completed its initial public offering in 2019.